MedPath
NMPA Approval

Trilaciclib Hydrochloride for Injection

国药准字HJ20220066

July 12, 2022

Drug Information

注射用盐酸曲拉西利

科赛拉

注射剂

300mg(按C₂₄H₃₀N₈O计)

化学药品

July 12, 2022

July 11, 2025

Company Information

Applicant Company

G1 Therapeutics

700 Park Offices Drive, Suite 200, Research Triangle Park, NC 27709, United States of America

Manufacturing Company

5900 Martin Luther King Jr. Highway Greenville, NC 27834 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.